The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit
later.
We apologize for any inconvenience caused
Advance in research of anti-HCV drugs and therapies
Author(s): YANG Xiao-yu, WANG Ju-xian, Beijing Hondsen Pharmaceutical Technology Co., Ltd., Institute of Medicinal Biotechnology, Beijing Union Medical College, Chinese Academy of Medical Sciences
Pages: 2624-
2630
Year: 2014
Issue:
22
Journal: Chinese Journal of New Drugs
Keyword: hepatitis C virus; combination therapy; trend of development;
Abstract: Hepatitis C virus can be divided to 6 genotypes and 70 subtypes. Due to no immunity and repeated infection,hepatitis C is a serious viral infectious disease to human health and very difficult to prevent. The use of interferon and ribavirin is still the main combination therapy to treat hepatitis C. In this paper,the types of anti-hepatitis C drug treatment,the development trends and market prospects were systematically summarized,to provide reference for the development of the new anti-HCV drugs.
Citations
No citation found